A Look At Catalyst Pharmaceuticals (CPRX) Valuation After Forbes 2026 Small Cap Recognition - Simply Wall St News

Litigation, Intellectual Property News

However, this hinges on Firdapse concentration and ongoing patent litigation, while generic pressure on Fycompa and rising SG&A could quickly ...

Related articles